X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (977) 977
Publication (124) 124
Book Review (34) 34
Book Chapter (19) 19
Book / eBook (3) 3
Magazine Article (3) 3
Conference Proceeding (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cannabidiol (713) 713
humans (528) 528
index medicus (516) 516
animals (335) 335
cannabinoids (325) 325
pharmacology & pharmacy (308) 308
cannabidiol - therapeutic use (301) 301
male (284) 284
cannabis (272) 272
neurosciences (226) 226
marijuana (221) 221
cannabidiol - pharmacology (195) 195
clinical neurology (193) 193
female (176) 176
psychiatry (152) 152
cannabinoids - therapeutic use (141) 141
tetrahydrocannabinol (141) 141
drug combinations (140) 140
mice (138) 138
pharmacology (121) 121
endocannabinoid system (118) 118
dronabinol - therapeutic use (116) 116
adult (109) 109
epilepsy (109) 109
plant extracts - therapeutic use (108) 108
delta-9-tetrahydrocannabinol (104) 104
multiple sclerosis (102) 102
health aspects (98) 98
medical marijuana (98) 98
rats (97) 97
analysis (96) 96
dronabinol (95) 95
treatment outcome (95) 95
delta-tetrahydrocannabinol (92) 92
disease models, animal (90) 90
multiple sclerosis - drug therapy (89) 89
thc (87) 87
care and treatment (85) 85
double-blind (83) 83
middle aged (82) 82
cannabidiol - administration & dosage (79) 79
cannabinoids - pharmacology (79) 79
muscle spasticity - drug therapy (79) 79
neurology (77) 77
spasticity (77) 77
drug therapy (73) 73
pain (72) 72
research (72) 72
dose-response relationship, drug (70) 70
schizophrenia (70) 70
cbd (69) 69
cannabinoid (68) 68
inflammation (68) 68
multiple-sclerosis (67) 67
multiple sclerosis - complications (62) 62
receptors (62) 62
cannabis - chemistry (61) 61
anticonvulsants - therapeutic use (59) 59
anxiety (58) 58
mental disorders (58) 58
cannabidiol - adverse effects (57) 57
clinical trials (56) 56
epilepsy - drug therapy (56) 56
usage (56) 56
medical marijuana - therapeutic use (55) 55
muscle spasticity - etiology (55) 55
psychosis (55) 55
double-blind method (54) 54
dronabinol - pharmacology (54) 54
review (53) 53
sativex (53) 53
endocannabinoids (52) 52
medicine (52) 52
cancer (51) 51
in-vitro (51) 51
seizures (51) 51
anandamide (50) 50
receptor (49) 49
symptoms (49) 49
digestive system diseases (48) 48
adolescent (46) 46
drug abuse (46) 46
in-vivo (46) 46
oxidative stress (46) 46
young adult (46) 46
cannabinoid receptors (45) 45
pain - drug therapy (45) 45
neuropathic pain (44) 44
brain (43) 43
dronabinol - adverse effects (43) 43
rodents (41) 41
article (40) 40
dronabinol - administration & dosage (39) 39
expression (39) 39
medical research (39) 39
studies (39) 39
activation (38) 38
drugs (38) 38
dosage and administration (37) 37
drug interactions (37) 37
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (966) 966
German (8) 8
Spanish (6) 6
Portuguese (4) 4
Danish (3) 3
French (3) 3
Japanese (3) 3
Hungarian (2) 2
Polish (2) 2
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
REVISTA BRASILEIRA DE PSIQUIATRIA, ISSN 1516-4446, 05/2010, Volume 32, pp. S56 - S66
Journal Article
La Revue du praticien, ISSN 0035-2640, 02/2014, Volume 64, Issue 2, p. 165
The therapeutic use of cannabis has generated a lot of interest in the past years, leading to a better understanding of its mechanisms of action. Countries... 
Pain - drug therapy | Antiemetics - therapeutic use | Dronabinol - analogs & derivatives | Fibromyalgia - drug therapy | Humans | Cannabidiol | Plant Extracts - therapeutic use | Dronabinol - therapeutic use | Drug Combinations | Muscle Spasticity - drug therapy | Multiple Sclerosis - drug therapy
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 04/2017, Volume 10, Issue 4, pp. 443 - 455
Introduction: The complexity of the endocannabinoid (eCB) system is becoming better understood and new drivers of eCB signaling are emerging. Modulation of the... 
cannabis | Cannabidiol | delta-9-tetrahydrocannabinol | endocannabinoid system | spasticity | multiple sclerosis | GUIDELINE DEVELOPMENT SUBCOMMITTEE | ALZHEIMERS-DISEASE | CB2 RECEPTOR | AMYLOID PATHOLOGY | MULTIPLE-SCLEROSIS SPASTICITY | NEUROPATHIC PAIN | ACID AMIDE HYDROLASE | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL
Journal Article
Journal Article
Current pharmaceutical biotechnology, ISSN 1389-2010, 2017, Volume 18, Issue 10, pp. 828 - 833
Since 2013 Cannabis-based preparations, containing the two main cannabinoids of interest, Δ9-tetrahydrocannabinol (THC), and cannabidiol (CBD), can be used for... 
cannabidiol | Δ9-tetrahydrocannabinol | LC-MS/MS | olive oil | cannabis preparations | therapeutic cannabinoids | n-Hexane | Temperature | Neurodegenerative diseases | Organic solvents | Therapeutic applications | Olive oil | Cannabis | Spectrometry | Cannabinoids | Dilution | Sample preparation | Acids | Reproducibility | Temperature effects | Polarity | Marijuana | Fats and oils | Tetrahydrocannabinol
Journal Article
Frontiers in Pharmacology, ISSN 1663-9812, 08/2016, Volume 7
Cannabis is classified as a schedule I controlled substance by the US Drug Enforcement Agency, meaning that it has no medicinal value. Production is legally... 
DEA controlled substances | Cannabinoids | Cannabis | Quality control | Therapeutics | Cannabidiol | Marijuana | Δ9-tetrahydrocannabinol (Δ9-THC) | cannabidiol | therapeutics | quality control | cannabis | cannabinoids | PHARMACOLOGY & PHARMACY | marijuana | Delta-tetrahydrocannabinol (Delta-THC) | Medical marijuana | Laws, regulations and rules | Distribution
Journal Article
CURRENT PHARMACEUTICAL BIOTECHNOLOGY, ISSN 1389-2010, 2017, Volume 18, Issue 10, pp. 828 - 833
Background: Since 2013 Cannabis-based preparations, containing the two main cannabinoids of interest,Delta 9-tetrahydrocannabinol (THC), and cannabidiol (CBD),... 
cannabidiol | LC-MS/MS | cannabis preparations | therapeutic cannabinoids | QUANTIFICATION | BIOCHEMISTRY & MOLECULAR BIOLOGY | olive oil | PHARMACOLOGY & PHARMACY | MASS-SPECTROMETRY | Delta 9-tetrahydrocannabinol
Journal Article
Frontiers in pharmacology, ISSN 1663-9812, 2016, Volume 7, p. 285
Cannabis is classified as a schedule I controlled substance by the US Drug Enforcement Agency, meaning that it has no medicinal value. Production is legally... 
Journal Article
Trends in Pharmacological Sciences, ISSN 0165-6147, 2009, Volume 30, Issue 10, pp. 515 - 527
Journal Article
Journal Article
Pharmacological Research, ISSN 1043-6618, 05/2016, Volume 107, pp. 85 - 92
Journal Article